Literature DB >> 1351171

Simvastatin use in children.

J Ducobu, D Brasseur, J M Chaudron, J P Deslypere, C Harvengt, E Muls, M Thomson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1351171     DOI： 10.1016/0140-6736(92)92092-t

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Role of lipid-lowering pharmacotherapy in children.

Authors:  S Tonstad
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

Review 2.  Lipid lowering in the young.

Authors:  G R Thompson
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

Review 3.  A rational approach to treating hypercholesterolaemia in children. Weighing the risks and benefits.

Authors:  S Tonstad
Journal:  Drug Saf       Date:  1997-05       Impact factor: 5.606

4.  Hyperlipidaemia, diet and simvastatin therapy in steroid-resistant nephrotic syndrome of childhood.

Authors:  J E Coleman; A R Watson
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

Review 5.  Choices for treatment of hyperlipidaemia.

Authors:  S Tonstad
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 6.  Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: a review.

Authors:  L Iughetti; B Predieri; F Balli; S Calandra
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

Review 7.  Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia.

Authors:  G L Plosker; D McTavish
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

8.  The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation.

Authors:  Albert Dirisamer; Nilouparak Hachemian; Robert Alexander Bucek; Florian Wolf; Markus Reiter; Kurt Widhalm
Journal:  Eur J Pediatr       Date:  2003-03-15       Impact factor: 3.183

Review 9.  Heterozygous familial hypercholesterolaemia in childhood: cardiovascular risk prevention.

Authors:  A van der Graaf; J J P Kastelein; A Wiegman
Journal:  J Inherit Metab Dis       Date:  2009-10-31       Impact factor: 4.982

10.  Effects of dietary cholesterol and simvastatin on cholesterol synthesis in Smith-Lemli-Opitz syndrome.

Authors:  Yen-Ming Chan; Louise S Merkens; William E Connor; Jean-Baptiste Roullet; Jennifer A Penfield; Julia M Jordan; Robert D Steiner; Peter J H Jones
Journal:  Pediatr Res       Date:  2009-06       Impact factor: 3.756
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.